Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone.

Source:http://linkedlifedata.com/resource/pubmed/id/18095238

Download in:

View as

General Info

Authors

Stewart M, Donaldson J, Paul G, Hamann A, Garcia-Puig J

Abstract

This 52-week, randomized, double-blind, parallel-group study was designed to compare rosiglitazone/metformin fixed-dose combination therapy with combination sulphonylurea plus metformin therapy in overweight individuals with inadequately controlled type 2 diabetes mellitus.

PMID
18095238

Publication types

Comparative Study; Randomized Controlled Trial